Our previous research demonstrated that Morgana is expressed at very low levels in the BM cells of patients affected by MDS/MPN with neutrophilia and is robustly downregulated in 30% of Ph + CML patients in chronic phase11. Here, CHORDC1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.